NB-5-MeO-DALT Oxalate Powder for Analytical Research in the USA and Europe

NB-5-MeO-DALT Oxalate Powder is a specialised analytical material whose identity must be confirmed from the supplier’s batch documentation. Public sources provide conflicting descriptions, including N-tert-butoxycarbonyl and N-benzyl structures, along with incompatible formulae and molecular masses. The product name alone is therefore insufficient to establish a reliable specification.wikipedia+3

Analytical Characterisation

A defensible batch record should include:

• HPLC or UPLC purity with method details.

• LC-MS or HRMS identity confirmation.

• NMR data supporting the proposed structure.

• Confirmation of oxalate content and salt stoichiometry.

• Residual-solvent testing.

• Water-content analysis where relevant.

• Elemental-impurity or heavy-metal results.

• Lot number, test date, and authorised CoA approval.

A “≥99% by HPLC” statement should be used only when supported by the CoA for the exact batch. It must specify whether the result applies to the parent derivative, total salt, or a particular assay calculation. Public listings report values around 98% and disagree on the molecular identity, so those descriptions should not be treated as authoritative.psychedelics-lab+1

The parent compound 5-MeO-DALT is distinct from NB-5-MeO-DALT. The parent free base is reported as C₁₇H₂₂N₂O, while its hydrochloride is separately catalogued as C₁₇H₂₃ClN₂O. Those data must not be transferred to an NB-protected oxalate without structural confirmation.pmc.ncbi.nlm.nih+1

Laboratory Applications

A verified sample may support strictly controlled analytical work, including:

• LC-MS or LC-MS/MS method development.

• Accurate-mass and fragmentation studies.

• NMR and spectroscopic structure comparison.

• Chromatographic selectivity and impurity profiling.

• Stability and degradation screening.

• Limited validation studies for precision, recovery, and detection limits.

These activities must be performed by qualified personnel in an appropriately authorised analytical, academic, forensic, or pharmaceutical research laboratory. The material should not be described as suitable for biological, clinical, therapeutic, or non-laboratory use.

Storage and Handling

Follow the current product-specific SDS and stability data. In the absence of validated stability information, keep the sealed powder dry, protected from direct light, and minimally exposed to air and atmospheric moisture. Avoid repeated temperature cycling and allow refrigerated packaging to reach room temperature before opening to reduce condensation.

Use a certified fume hood or equivalent local-exhaust enclosure. Suitable controls include a laboratory coat, nitrile gloves, chemical splash goggles, controlled weighing, dust minimisation, and approved chemical-waste procedures. Do not publish a specific solubility or stock-solution concentration without product-specific experimental data.

USA and European Compliance

Legal treatment may vary between US federal and state authorities, EU Member States, the UK, and other European jurisdictions. Public sources report that the parent 5-MeO-DALT is not federally scheduled in the United States but may be controlled under state law or analogue provisions; those claims should not be assumed to apply automatically to NB-5-MeO-DALT Oxalate.wikipedia+2

Before possession, importation, transport, analysis, storage, or disposal, the laboratory must obtain current advice from the relevant authority or qualified compliance professional. A “research chemical” label does not itself establish lawful status.

Technical Specifications